APA (7th ed.) Citation

Mitiushkina, N. V., Romanko, A. A., Preobrazhenskaya, E. V., Tiurin, V. I., Ermachenkova, T. I., Martianov, A. S., . . . Imyanitov, E. N. (2022). Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer. Cancer Medicine, 11(17), 3226. https://doi.org/10.1002/cam4.4686

Chicago Style (17th ed.) Citation

Mitiushkina, Natalia V., et al. "Comprehensive Evaluation of the Test for 5′‐/3′‐end MRNA Unbalanced Expression as a Screening Tool for ALK and ROS1 Fusions in Lung Cancer." Cancer Medicine 11, no. 17 (2022): 3226. https://doi.org/10.1002/cam4.4686.

MLA (9th ed.) Citation

Mitiushkina, Natalia V., et al. "Comprehensive Evaluation of the Test for 5′‐/3′‐end MRNA Unbalanced Expression as a Screening Tool for ALK and ROS1 Fusions in Lung Cancer." Cancer Medicine, vol. 11, no. 17, 2022, p. 3226, https://doi.org/10.1002/cam4.4686.